Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genpact (G) Asset Writedowns and Impairment: 2009-2024

Historic Asset Writedowns and Impairment for Genpact (G) over the last 16 years, with Dec 2024 value amounting to $13.8 million.

  • Genpact's Asset Writedowns and Impairment was N/A to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year change of. This contributed to the annual value of $13.8 million for FY2024, which is 246.97% up from last year.
  • Genpact's Asset Writedowns and Impairment amounted to $13.8 million in FY2024, which was up 246.97% from $4.0 million recorded in FY2023.
  • Genpact's Asset Writedowns and Impairment's 5-year high stood at $32.6 million during FY2022, with a 5-year trough of $1.5 million in FY2021.
  • Its 3-year average for Asset Writedowns and Impairment is $16.8 million, with a median of $13.8 million in 2024.
  • In the last 5 years, Genpact's Asset Writedowns and Impairment slumped by 89.44% in 2021 and then spiked by 2,090.65% in 2022.
  • Genpact's Asset Writedowns and Impairment (Yearly) stood at $14.1 million in 2020, then plummeted by 89.44% to $1.5 million in 2021, then skyrocketed by 2,090.65% to $32.6 million in 2022, then slumped by 87.79% to $4.0 million in 2023, then soared by 246.97% to $13.8 million in 2024.